| Gene symbol | CD5 | Synonyms | LEU1, T1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD5 molecule | ||||
| GTO ID | GTC0892 |
| Trial ID | ChiCTR2000039519 |
| Disease | T-Cell Acute Lyphoblastic Leukemia |
| Altered gene | CD5 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD5 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A single-center, open, non-randomized, single-arm clinical trial of donor CD5-CAR T cells in the treatment of refractory/relapsed acute T lymphoblastic leukemia in children |
| Year | 2020 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||
|
|||||||